The connection between sleep and health has been recognised for centuries, but it is only relatively recently that the treatment of sleep disorders has developed as a medical specialty.

Patient-centred practice is needed to build a treatment plan that works for individual patients.

This study shows the importance of sharing and learning from policy differences.

Living with haemochromatosis is an individual journey that requires consistent, medically supported self-management guided by a positive attitude and awareness of the condition.

Interconception care is becoming increasingly important, with rising rates of overweight, obesity, diabetes and hypertension among people of reproductive age.

The primary care physician has an essential role in providing women with guidance, counselling and assessment regarding fertility concerns.

General practitioners are well positioned to take a comprehensive approach to the management of functional decline in older people, aided by a range of funded programs.

Young people experience higher rates of sexually transmissible infections and lower screening rates than the general population in Australia.

Diagnosis of insomnia is facilitated by the use of self-report measures to characterise the sleep disorder and elucidate comorbidities.

Involving patients in the clinical decision-making process is integral to providing individualised care and is promoted as a hallmark of good clinical practice.

The enhanced Residential Medication Management Review program will address barriers and support general practitioners to make medication changes for older Australians.

An updated overview of Burkholderia pseudomallei, the causative agent of melioidosis, including epidemiology, risk factors for infection, spectrum of clinical disease, diagnosis and management.

Effective insomnia treatment requires a multidisciplinary team that is centred on the patient’s preference and personal goals.

How should GPs and patients prioritise which preventive health activities to undertake?

Prescribing drugs to reduce the risk of cancer is a new development in primary cancer prevention.